Line 1: |
Line 1: |
− | {{unfinished}} | + | {{review}} |
| | | |
| {{dog}} | | {{dog}} |
Line 15: |
Line 15: |
| **[[Canine Breeds - WikiNormals#Utility Group|Standard Poodle]] | | **[[Canine Breeds - WikiNormals#Utility Group|Standard Poodle]] |
| **[[Canine Breeds - WikiNormals#Working Group|Boxer]] | | **[[Canine Breeds - WikiNormals#Working Group|Boxer]] |
| + | |
| | | |
| ==Description== | | ==Description== |
| '''Insulinomas''' are slow growing, well-encapsulated, functional tumours of the [[Pancreas - Anatomy & Physiology#Endocrine|beta cells]] of the pancreatic islet cells. They secrete inappropriately high amount of [[Pancreas - Anatomy & Physiology#Insulin|insulin]] irrespective of the serum glucose level. They are predominantly [[Neoplasia - Pathology#Classification|malignant]] (90% of canine insulinomas), with a high metastatic rate to regional [[Lymph Nodes - Pathology|lymph nodes]], [[Liver - Anatomy & Physiology|liver]] and omentum. 60% of isulinomas are [[Neoplasia - Pathology#Nomenclature|carcinomas]], which are more likely to be endocrinologically active, the others being [[Neoplasia - Pathology#Nomenclature|adenomas]]. | | '''Insulinomas''' are slow growing, well-encapsulated, functional tumours of the [[Pancreas - Anatomy & Physiology#Endocrine|beta cells]] of the pancreatic islet cells. They secrete inappropriately high amount of [[Pancreas - Anatomy & Physiology#Insulin|insulin]] irrespective of the serum glucose level. They are predominantly [[Neoplasia - Pathology#Classification|malignant]] (90% of canine insulinomas), with a high metastatic rate to regional [[Lymph Nodes - Pathology|lymph nodes]], [[Liver - Anatomy & Physiology|liver]] and omentum. 60% of isulinomas are [[Neoplasia - Pathology#Nomenclature|carcinomas]], which are more likely to be endocrinologically active, the others being [[Neoplasia - Pathology#Nomenclature|adenomas]]. |
| + | |
| | | |
| ==Diagnosis== | | ==Diagnosis== |
Line 45: |
Line 47: |
| | | |
| For pathology see [[Endocrine Pancreas - Pathology|Insulinoma]] | | For pathology see [[Endocrine Pancreas - Pathology|Insulinoma]] |
| + | |
| | | |
| ===Diagnostic Imaging=== | | ===Diagnostic Imaging=== |
Line 52: |
Line 55: |
| ====Ultrasonography==== | | ====Ultrasonography==== |
| Occasionally, it may be possible to visualise the location of the tumour on the [[Pancreas - Anatomy & Physiology|pancreas]]. However, this may not always be possible, especially if the tumour is too small. Metastases to [[Lymph Nodes - Anatomy & Physiology|lymph nodes]] and [[Liver - Anatomy & Physiology|liver]] can sometimes be seen. | | Occasionally, it may be possible to visualise the location of the tumour on the [[Pancreas - Anatomy & Physiology|pancreas]]. However, this may not always be possible, especially if the tumour is too small. Metastases to [[Lymph Nodes - Anatomy & Physiology|lymph nodes]] and [[Liver - Anatomy & Physiology|liver]] can sometimes be seen. |
| + | |
| | | |
| ==Treatment== | | ==Treatment== |
Line 68: |
Line 72: |
| ===Surgery=== | | ===Surgery=== |
| A partial pancreatectomy is suitable for patients with a solitary tumour, provided there is no metastasis. Complications such as persistent hypoglycaemia, [[Pancreatitis - WikiClinical|pancreatitis]], diabetes mellitus, epilepsy and diffuse polyneuropathy can occur. | | A partial pancreatectomy is suitable for patients with a solitary tumour, provided there is no metastasis. Complications such as persistent hypoglycaemia, [[Pancreatitis - WikiClinical|pancreatitis]], diabetes mellitus, epilepsy and diffuse polyneuropathy can occur. |
| + | |
| | | |
| ==Prognosis== | | ==Prognosis== |